Sitemap

• Products
  • DIOR
    • Product information
    • Technical Information
    • Order Information
  • E-MAGIC PLUS
    • Product information
    • Technical Information
    • Order Information
  • APERTUS Aspiration Catheter
    • Product information
    • Product specification
    • Order Information
  • Genius MAGIC
    • Product information
    • Media
    • Order information
  • AMADEUS SUPERCROSS
    • Product information
    • Scientific data
    • Order information
  • FREEWAY 014
    • Product information
    • Technical data
    • Order information
  • FREEWAY 035
    • Product information
    • Technical data
    • Order information
  • FREEWAY Shunt Balloon Catheter
    • Product information
    • Technical data
    • Order information
  • JOKER 014
    • Product information
    • Technical data
    • Order information
  • JOKER 035
    • Product information
    • Technical data
    • Order information
• About us
  • Management
  • Meetings and Conventions
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
  • Talks and Presentations
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
  • Jobs & Career
    • Job offers at Eurocor
    • Unsolicited applications
• Press & News
  • Eurocor at LINC 2018
  • Visit our Exhibition Stand #13 at the GulfPCR
  • Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen on Sept. 18, 2017
  • CIRSE 2017 in Copenhagen
  • Eurocor in Paris: EuroPCR 2017
  • Visit our Exhibition Stand #31 at CICE Congress 2017
  • Eurocor announces the completion of the Freeway Stent Study
  • LINC 2017
  • IROS 2017
  • Visit our Exhibition Stand #12 at the GulfPCR
  • Eurocor enters the market with their FREEWAY™ COATED SHUNT BALLOON CATHETER
  • Eurocor in Barcelona: CIRSE 2016
  • Eurocor FREEWAY™ – COATED SHUNT BALLOON CATHETER launch
  • Results of DEBIFU registry are presented during EuroPCR
  • Eurocor in Paris: EuroPCR 2016
  • Eurocor Receives CE Mark Approval for E-Magic Plus™ SES
  • Eurocor participates to LINC Congress in Leipzig (Germany)
  • Eurocor launches APERTUS Aspiration Catheter
  • Interim Results of the Freeway Stent Study presented at TCT 2013
  • Eurocors Valentines Trial II published in EuroIntervention
  • Eurocor’s partner - Micell Technologies Receives CE Mark Approval for MiStent SES
  • Eurocor Enters into Licensing Agreement with Biosensors for Drug-eluting Balloon Range
  • Eurocor Abstracts ranked and honored at CRT Congress 2013
  • Eurocor to be present at CRT Congress in Washington DC (USA)
  • Eurocor to be present at Arab Health congress, Dubai (United Arabian Emirates)
  • Eurocor participates LINC Congress in Leipzig (Germany)
  • Eurocor announces interim results of the Freeway™ Stent Study at IROS Congress
  • Eurocor to present interim results of Freeway Stent Study at IROS Congress
  • Eurocor’s DEBIFU Registry successfully enrolled first patients
  • Eurocor participates CIRSE Congress in Lisbon
  • Results from the DiabEtic Argentina Registry (DEAR) published ahead of print in Cardiovascular Revascularization Medicine Journal
  • Opto Circuits launches its first Sirolimus Drug Eluting Stent
  • Eurocor supports Sailing Trip for children with heart diseases
  • Eurocor to be present at SOLACI Congress, Mexico City
  • Valentines Trial II results presented at EuroPCR 2012 in Paris
  • Eurocor announces presentation of Valentines Trial II results at CRT2012
  • Eurocor announces first insights of the Freeway Stent Study at LINC Congress
  • JIM Joint Interventional Meeting 2012
  • CRT Cardiovascular Research Technologies 2012
  • Eurocor announces treatment of First Patients in International Randomized Freeride Study
  • LINC - Leipzig Interventional Course
  • Eurocor is present at IROS Congress
  • There is no time more fitting to say thank you
  • DIOR® DEB shows remarkable performance in diabetics
  • Dr. Antonino Laudani Joins Eurocor GmbH as Chief Operating Officer
  • Eurocor with new Distributor in the UK and Ireland
  • Eurocor is present on the the 32nd National Congress of the Italian Society of Invasive Cardiology (GISE)
  • Eurocor is taking part at the 66° Congresso Brasileiro de Cardiologia, Porto Alegre, Brazil
  • Successful Eurocor symposium about drug-eluting balloons at CIRSE in Munich
  • Eurocor launches FREEWAY™ DEB in Venezuela
  • Eurocors Valentines Trial published in EuroIntervention
  • Eurocor is taking part at the Great Wall International Congress of Cardiology in Beijing, China
  • Eurocor is present on the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
  • Micell Technologies completes enrolment in DESSOLVE II study
  • Eurocor allows sailing trip for children with heart disease
  • Eurocor is present on the annual meeting of the Swiss Society for Cardiology (SGK)
  • DIOR® DEB shows remarkable performance in diabetics with coronary lesions
  • Eurocor is present on the "Röntgenkongress" in Hamburg
  • Eurocor’s partner Micell reported data for MiStentTM DES
  • Eurocor had a successful presence at EuroPCR 2011 in Paris
  • Eurocor presented 12 months outcomes of Spanish Registry on the occasion of EuroPCR in Paris
  • Eurocor in Paris: EuroPCR 2011
  • Eurocor GmbH today announced the launch of DIOROCT Trial with PI Prof. Patrick W. Serruys
  • Final data of Valentines Trial I
  • Eurocor GmbH announces Study results of Valentines Trial I
  • Eurocor launched Magical in India
  • Valentines Trial II
  • Eurocor Steps Up Research Activities
  • LINC - The Leipzig Interventional Course
  • Eurocor participates IROS Congress, January 13 - 15 2011
  • Eurocor launches FREEWAY
  • Eurocor at CACI-TCT, Argentina
  • Eurocor participates SAINT Congress, September 10 - 11, 2010
  • Eurocor participates TCT Conference, September 21 - 25, 2010
  • Eurocor presented successful symposium at SOLACI
  • Eurocor completes successful trade-fair appearance at SOLACI
  • Eurocor successfully presents Drug Eluting Balloon DIOR to Asian cardiologists
  • DIOR catheter: early success in Canada
  • Eurocor: Convincing initial results in the DIOR Debiut study
  • Eurocor completes successful trade-fair appearance in Paris
  • EuroPCR 2010: Press release
  • Eurocor in Paris: EuroPCR 2011
  • The Valentines Trial - Enrolment finished
  • Interims results of “DIOR – the Spanish registry”
  • The Spanish Multicenter Registry
  • Patient Enrollment for the Valentines Trial
  • Eurocor at EuroPCR 2009
  • The first-in-man aortic valvuloplasty with a drug-eluting balloon
  • Eurocor launches DIOR at the JIM 2007 successfully.
• Contact & Locations
  • Contact form